Prevalence of the Metabolic Syndrome in Psoriasis
Open Access
- 1 April 2011
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 147 (4), 419-424
- https://doi.org/10.1001/archdermatol.2010.370
Abstract
Psoriasis is a chronic, inflammatory disease of the skin that affects approximately 2% of the population1-4 and poses a lifelong burden for those affected.1 A survey by the National Psoriasis Foundation found that 75% of patients with psoriasis reported a moderate to large negative impact of the disease on the quality of their life, with an alteration of everyday activities.5Keywords
This publication has 40 references indexed in Scilit:
- Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research DatabaseEuropean Heart Journal, 2009
- Psoriasis and the Risk of Diabetes and HypertensionArchives of Dermatology, 2009
- The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004Journal of the American Academy of Dermatology, 2008
- The Risk of Mortality in Patients With PsoriasisArchives of Dermatology, 2007
- Prevalence of cardiovascular risk factors in patients with psoriasisJournal of the American Academy of Dermatology, 2006
- Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasisArchives of Dermatological Research, 2006
- Prevalence and Treatment of Psoriasis in the United KingdomArchives of Dermatology, 2005
- The prevalence of psoriasis in African Americans: Results from a population-based studyJournal of the American Academy of Dermatology, 2005
- Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and WomenArchives of Internal Medicine, 2004
- Insulin resistance and cigarette smokingThe Lancet, 1992